[ORGANIZATION]

Saxenda (liraglutide)

Featured in 1 tracked story · first seen about 2 hours ago

Situations

[ACTIVE] [HEALTH] [BUSINESS] [CRIME] [US] [BR] [GB]

GLP‑1 weight‑loss drugs: safety, policy and clinical rollout

188 clusters · 689 sources · last updated 1 day ago

Latest: Anvisa bans unregistered weight‑loss products while planning approval of eight new GLP‑1 pens

Since mid‑2026, the rapid expansion of GLP‑1 agents for obesity has been accompanied by growing emphasis on complementary diet, insurance constraints and emerging safety signals. Clinical experts in the United States and